Antibiotic Developments
nobeastsofierce Shutterstock
Glox Therapeutics awarded grant to accelerate development of precision antibiotics
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).
25 Nov 2024
Sawyer0/Adobe Stock
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol).
17 Oct 2024
Shutterstock
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges.
8 Mar 2024
SIRIO Launches New Consumer Health Gummies at CPHI Barcelona
Sirio Pharma will further expand its offering in the consumer health market, building on last month’s ‘pharma targeted’ softgel launch, with the introduction of a range of herbal gummies for trending consumer health categories.
6 Oct 2023
ANL and SoundCell awarded grant for antibiotic sensitivity test
Applied Nanolayers BV (ANL) and SoundCell BV have received €275,000 R&D funding from Provincie Zuid-Holland to develop a prototype for SoundCell’s high throughput single-cell graphene antibiotic sensitivity test.
27 Mar 2023
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit.
8 Aug 2022
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process.
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research.
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance.
29 Nov 2021
Sponsored Content
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Photon photo Shutterstock
Rare disease biotech announces milestone
Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials.
13 Jun 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Schneider Electric
Schneider Electric launches new data centre solutions
Schneider Electric, a company in the digital transformation of energy management and automation, has announced new data centre solutions specifically engineered to meet the intensive demands of next-generation AI cluster architectures.
13 Jun 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
CKA Shutterstock
RBQM event returns for 2025
CluePoints, the sponsor of RBQMLive and provider of statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual RBQMLive.
13 Jun 2025
Body Stock Shutterstock
XL-protein grants worldwide license to Grifols
XL-protein has announced that it has entered into a worldwide License, Development and Commercialisation Agreement with Grifols for a long-acting biopharmaceutical product.
12 Jun 2025
Dmitry Demidovich Shutterstock
Tagomics awarded £860k Innovate UK Biomedical Catalyst grant
Tagomics, a biomarker discovery and diagnostics company, has announced it has been awarded £860k Innovate UK funding as part of the Biomedical Catalyst programme for the testing and development of innovative healthcare solutions from Innovate UK.
12 Jun 2025
Pharma Manufacturing News + Pharma Finance and Investment News
laraslk Shutterstock
European Commission approves treatment for Duchenne muscular dystrophy
Italfarmaco has announced that the European Commission (EC) has granted conditional marketing authorisation for Duvyzat (givinostat), a novel histone deacetylase (HDAC) inhibitor.
11 Jun 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00